Cardinal Analytx has raised $20.6m of a targeted $29.3m, adding to a 2017 series A round that included Premera Blue Cross in 2017.

Cardinal Analytx, a US-based population health management provider backed by health insurance provider Premera Blue Cross, has received $20.6m in series B funding from undisclosed investors, according to a securities filing.

The company is targeting a $29.3m final close, the filing states, but it has not yet made any formal announcements concerning the round.

Founded in 2013, Cardinal Analytx has developed machine learning and artificial intelligence technology that predicts which health insurance customers are at a higher risk of illness,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.